Standout Papers

A Contemporary Prostate Cancer Grading Sy... 2001 2026 2009 2017 916
  1. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score (2015)
    Jonathan I. Epstein, Michael J. Zeléfsky et al. European Urology
  2. Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer (2008)
    Rong Hu, Thomas A. Dunn et al. Cancer Research
  3. LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY (2001)
    Misop Han, Alan W. Partin et al. Urologic Clinics of North America
  4. CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS (2004)
    Kimberly A. Roehl, Misop Han et al. The Journal of Urology
  5. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2003)
    Misop Han, Alan W. Partin et al. The Journal of Urology
  6. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2003)
    Misop Han, Alan W. Partin et al. The Journal of Urology
  7. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy (2011)
    Scott E. Eggener, Peter T. Scardino et al. The Journal of Urology
  8. Prostate Specific Antigen Best Practice Statement: 2009 Update (2009)
    Kirsten L. Greene, Peter C. Albertsen et al. The Journal of Urology
  9. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening (2023)
    John T. Wei, Daniel A. Barocas et al. The Journal of Urology

Immediate Impact

2 by Nobel laureates 15 from Science/Nature 95 standout
Sub-graph 1 of 16

Citing Papers

Prostate Cancer
2025 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
8 intermediate papers

Works of Misop Han being referenced

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
2019
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men
2015
and 7 more

Author Peers

Author Last Decade Papers Cites
Misop Han 9714 2122 2249 223 11.8k
Joseph C. Presti 7703 2405 1987 237 10.3k
Christopher L. Amling 7435 2017 1594 286 10.1k
Kevin M. Slawin 6736 1470 1822 180 9.7k
R. Jeffrey Karnes 8341 2770 1862 424 12.1k
Andrew J. Stephenson 7603 3262 1694 241 10.3k
Martha K. Terris 8403 2050 2794 383 11.1k
Nicolas Mottet 6274 1380 1416 140 8.0k
Thomas Wiegel 7655 1787 1498 224 9.8k
Arnauld Villers 10112 2209 3219 335 12.4k
Alexander Haese 7132 1585 1950 257 8.9k

All Works

Loading papers...

Rankless by CCL
2026